
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“NSAID use and risk of Parkinson disease: a population-based case-control study”, Eur J Neurol, vol. 18, pp. 1336-42, 2011.
, “Parkinson's disease or Parkinson symptoms following seasonal influenza”, Influenza Other Respir Viruses, vol. 5, pp. 328-33, 2011.
, “Risk of incident depression in patients with Parkinson disease in the UK”, Eur J Neurol, vol. 18, pp. 448-53, 2011.
, “Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database”, Bmj, vol. 342, p. d2139, 2011.
, “Statin use and risk of first-time psoriasis diagnosis”, J Am Acad Dermatol, vol. 65, pp. 77-83, 2011.
, “Use of metformin and the risk of ovarian cancer: a case-control analysis”, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
, “Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study”, BMC Neurol, vol. 10, p. 6, 2010.
, “Cancer risk in association with Parkinson disease: a population-based study”, Parkinsonism Relat Disord, vol. 16, pp. 186-90, 2010.
, “Chronic obstructive pulmonary disease and the risk of cardiovascular diseases”, Eur J Epidemiol, vol. 25, pp. 253-60, 2010.
, “COPD and the risk of depression”, Chest, vol. 137, pp. 341-7, 2010.
, “Long-term metformin use is associated with decreased risk of breast cancer”, Diabetes Care, vol. 33, pp. 1304-8, 2010.
, “Reflux disease, gastrointestinal ulcer or weight loss in patients with COPD”, Copd, vol. 7, pp. 172-8, 2010.
, “Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study”, Ann Intern Med, vol. 152, pp. 78-84, 2010.
, “Risk of stroke in patients with idiopathic Parkinson disease”, Parkinsonism Relat Disord, vol. 16, pp. 31-5, 2010.
, “Use of depot medroxyprogesterone acetate and fracture risk”, J Clin Endocrinol Metab, vol. 95, pp. 4909-16, 2010.
, “Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study”, Eur J Neurol, vol. 16, pp. 745-51, 2009.
, “Lithium, antipsychotics, and risk of psoriasis”, J Clin Psychopharmacol, vol. 29, pp. 134-40, 2009.
, “Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis”, J Invest Dermatol, vol. 129, pp. 2604-12, 2009.
, “Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis”, Br J Dermatol, vol. 160, pp. 1048-56, 2009.
, “Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 445-53, 2009.
, “Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 514-24, 2009.
, “The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database”, Contraception, vol. 80, pp. 142-51, 2009.
, “Statin use and risk of gallstone disease followed by cholecystectomy”, Jama, vol. 302, pp. 2001-7, 2009.
, “Antidepressant drug use and risk of venous thromboembolism”, Pharmacotherapy, vol. 28, pp. 144-50, 2008.
, “Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study”, Br J Dermatol, vol. 158, pp. 1299-307, 2008.
, “Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study”, J Am Acad Dermatol, vol. 58, pp. 421-9, 2008.
, “Diabetes in patients with idiopathic Parkinson's disease”, Diabetes Care, vol. 31, pp. 1808-12, 2008.
, “Migraine incidence, comorbidity and health resource utilization in the UK”, Cephalalgia, vol. 28, pp. 57-64, 2008.
, “Psoriasis and the risk of incident diabetes mellitus: a population-based study”, Br J Dermatol, vol. 159, pp. 1331-7, 2008.
, “The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions”, Headache, vol. 48, pp. 606-10, 2008.
, “Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK”, Drug Saf, vol. 31, pp. 399-407, 2008.
, “Use of thiazolidinediones and fracture risk”, Arch Intern Med, vol. 168, pp. 820-5, 2008.
, “Diclofenac and acute myocardial infarction in patients with no major risk factors”, Br J Clin Pharmacol, vol. 64, pp. 662-7, 2007.
, “Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort”, J Neurol, vol. 254, pp. 1736-41, 2007.
, “Migraine and the risk of stroke, TIA, or death in the UK (CME)”, Headache, vol. 47, pp. 1374-84, 2007.
, “Statins and the risk of pneumonia: a population-based, nested case-control study”, Pharmacotherapy, vol. 27, pp. 325-32, 2007.
, “Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis”, Neurology, vol. 66, pp. 572-5, 2006.
, “Antibiotic use and risk of multiple sclerosis”, Am J Epidemiol, vol. 163, pp. 997-1002, 2006.
, “Glucocorticoid use, other associated factors, and the risk of tuberculosis”, Arthritis Rheum, vol. 55, pp. 19-26, 2006.
, “Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors”, Pharmacotherapy, vol. 26, pp. 1379-87, 2006.
, “Cigarette smoking and the progression of multiple sclerosis”, Brain, vol. 128, pp. 1461-5, 2005.
, “Recent use of oral contraceptives and the risk of multiple sclerosis”, Arch Neurol, vol. 62, pp. 1362-5, 2005.
, “Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database”, Br J Clin Pharmacol, vol. 60, pp. 76-82, 2005.
, “Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina”, Cancer, vol. 103, pp. 1114-21, 2005.
, “Antidepressants and the risk of suicidal behaviors”, Jama, vol. 292, pp. 338-43, 2004.
, “Inhaled corticosteroids and the risk of fractures in children and adolescents”, Pediatrics, vol. 114, pp. 469-73, 2004.
, “Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study”, Neurology, vol. 63, pp. 838-42, 2004.
, “The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials”, Drug Saf, vol. 27, pp. 203-13, 2004.
, “Statins and newly diagnosed diabetes”, Br J Clin Pharmacol, vol. 58, pp. 303-9, 2004.
, “Tamoxifen and cataracts: a null association”, Breast Cancer Res Treat, vol. 87, pp. 189-96, 2004.
,